Originele taal-2 | English |
---|---|
Pagina's (van-tot) | S423-S424 |
Aantal pagina's | 2 |
Tijdschrift | Journal of Crohn's and Colitis |
Volume | 11 |
Status | Published - 1-feb.-2017 |
Early suppression of the serological macrophage activity biomarker VICM, and not suppression of CRP, predicts the response to infliximab in Crohn's disease patients
J. H. Mortensen, W. T. van Haaften, M. L. Olesen, M. Karsdal, P. Olinga, G. Dijkstra, A. -C. Bay-Jensen
Onderzoeksoutput: Meeting Abstract › Academic